"Le Centre Hospitalier Privé Sainte Marie est un établissement de santé pluridisciplinaire situé à Osny, en Ile-de-France. Il fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée. L’établissement est équipé de 191 lits (médicalisés) au sein de chambres climatisées. Il dispose également d’un service d’urgences ouvert 24h/24 et 7 jours sur 7. Différents pôles médicaux-chirurgicaux vous sont également proposés tels que : - la médecine oncologique - la chimiothérapie ambulatoire - la chirurgie de la main - l'endoscopie - la prise en charge de l’obésité"

During the past decade, Clinique Ste - Marie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Ste - Marie" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 7 trials, followed by "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored, "Robert Roessle Klinik" with 1 trials sponsored and "UNICANCER" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Ste - Marie" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 1 trials as a collaborator and "Grupo Espanol Tratamiento Tumores Digestivos" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Ste - Marie" are "Pancreatic Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Esophageal Cancer" (2 trials), "Anal Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Clinique Ste - Marie" in a lesser frequency.

Most popular intervention types in "Clinique Ste - Marie" are "Drug" (10 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (8 trials), "leucovorin calcium" (5 trials), "radiation therapy" (4 trials), "cisplatin" (3 trials) and "gemcitabine hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Ste - Marie" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Ste - Marie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinique Ste - Marie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Ste - Marie, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".